Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Gross ProfitOther Operating ExpensesRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mainz Biomed N.V (MYNZ) Income from Continuing Operations: 2019-2024

Historic Income from Continuing Operations for Mainz Biomed N.V (MYNZ) over the last 6 years, with Dec 2024 value amounting to -$21.7 million.

  • Mainz Biomed N.V's Income from Continuing Operations rose 36.70% to -$5.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$26.3 million, marking a year-over-year increase of 0.35%. This contributed to the annual value of -$21.7 million for FY2024, which is 17.66% up from last year.
  • As of FY2024, Mainz Biomed N.V's Income from Continuing Operations stood at -$21.7 million, which was up 17.66% from -$26.3 million recorded in FY2023.
  • In the past 5 years, Mainz Biomed N.V's Income from Continuing Operations ranged from a high of -$586,895 in FY2020 and a low of -$26.4 million during FY2022.
  • Over the past 3 years, Mainz Biomed N.V's median Income from Continuing Operations value was -$26.3 million (recorded in 2023), while the average stood at -$24.8 million.
  • Its Income from Continuing Operations has fluctuated over the past 5 years, first soared by 38.68% in 2020, then tumbled by 1,891.86% in 2021.
  • Mainz Biomed N.V's Income from Continuing Operations (Yearly) stood at -$586,895 in 2020, then crashed by 1,891.86% to -$11.7 million in 2021, then plummeted by 125.72% to -$26.4 million in 2022, then rose by 0.35% to -$26.3 million in 2023, then grew by 17.66% to -$21.7 million in 2024.